The overall pooled data revealed that patients in the LH group were less likely to suffer liver failure than those in the OH group (RR = 0.41; 95% CI, 0.27~0.64; P < 0.01) (Figure 3(b)). This evidence concerns the gene PLOD1 and Hepatic failure.